Oric Pharmaceuticals' GAAP loss for 9M 2021 was $55.944 million, up 23.1% from $45.444 million in the prior year.
Oric Pharmaceuticals' GAAP loss for 9M 2021 was $55.944 million, up 23.1% from $45.444 million in the prior year.
Financial results
Oric Pharmaceuticals' GAAP loss for 9M 2021 was $55.944 million, up 23.1% from $45.444 million in the prior year. Source: 
investors.oricpharma.com
investors.oricpharma.com
English (US) 